# Risk Stratification: Vitamin A (Retinol) - Functional Medicine Perspective

**Last Updated:** January 2026
**Target Population:** Adults (18+ years)
**Test:** Serum/Plasma Retinol
**Primary Units:** µg/dL (micrograms per deciliter)
**Alternative Units:** µmol/L (micromoles per liter)

---

## Executive Summary

Vitamin A (retinol) exhibits a **U-shaped risk curve** where both deficiency and toxicity pose significant health risks. Functional medicine approaches emphasize maintaining levels within a narrower "optimal" range (57-66 µg/dL per OptimalDX) compared to standard laboratory ranges (38-98 µg/dL), focusing on disease prevention and performance optimization rather than merely avoiding pathology.

**Critical Safety Considerations:**
- **Teratogenicity:** Doses >10,000 IU/day (3,000 µg/day) are associated with birth defects
- **Hepatotoxicity:** Chronic intake >25,000 IU/day can cause liver damage
- **Pregnancy:** Upper limit is 3,000 µg RE/day (10,000 IU/day)
- **Vitamin D Interaction:** High vitamin A can antagonize vitamin D; optimal ratio debated (4:1 to 10:1)

---

## Unit Conversion

**Conversion Factor:**
- **1 µmol/L = 28.6 µg/dL**
- **1 µg/dL = 0.035 µmol/L**

**Dietary to Serum:**
- 900 µg RAE/day (RDA men) → typically maintains 48-63 µg/dL
- 700 µg RAE/day (RDA women) → typically maintains 48-63 µg/dL
- 3,000 µg/day = Upper Limit (UL) for adults

**International Units:**
- 1 µg RAE = 3.33 IU (from retinol)
- 10,000 IU/day = 3,000 µg/day (teratogenic threshold)

---

## Risk Stratification Table (7 Levels)

### Level-Based Classification

| Level | Risk Category | Range (µg/dL) | Range (µmol/L) | Clinical Significance |
|-------|--------------|---------------|----------------|----------------------|
| **0** | Severe Deficiency | <10 | <0.35 | Critical - Immediate intervention |
| **1** | Moderate Deficiency | 10-19.9 | 0.35-0.69 | High risk - Symptomatic |
| **2** | Mild Deficiency | 20-37.9 | 0.70-1.32 | Suboptimal - Early symptoms |
| **3** | Low-Normal | 38-56.9 | 1.33-1.98 | Functional deficiency possible |
| **4** | **OPTIMAL** | **57-66** | **1.99-2.30** | **Target range for health optimization** |
| **5** | High-Normal | 66.1-85 | 2.31-2.97 | Generally safe, monitor intake |
| **6** | Elevated/Risk | >85 | >2.97 | Risk of toxicity - Reduce intake |

### Extended Classification (9 Levels - Detailed)

| Level | Risk Category | Range (µg/dL) | Range (µmol/L) | Clinical Significance |
|-------|--------------|---------------|----------------|----------------------|
| **0** | Critical Deficiency | <10 | <0.35 | Severe xerophthalmia, blindness risk |
| **1** | Severe Deficiency | 10-15 | 0.35-0.52 | Night blindness, immune compromise |
| **2** | Moderate Deficiency | 15.1-19.9 | 0.53-0.69 | WHO deficiency threshold |
| **3** | Mild Deficiency | 20-37.9 | 0.70-1.32 | Subclinical symptoms |
| **4** | Low-Normal | 38-56.9 | 1.33-1.98 | Standard lab "normal" but suboptimal |
| **5** | **OPTIMAL** | **57-66** | **1.99-2.30** | **Functional medicine target** |
| **6** | High-Normal | 66.1-75 | 2.31-2.62 | Safe, adequate stores |
| **7** | Upper Normal | 75.1-85 | 2.63-2.97 | Monitor intake, assess supplementation |
| **8** | Elevated/Toxicity Risk | >85 | >2.97 | Hepatotoxicity risk, discontinue supplements |

---

## CSV Format Output (7 Levels)

```csv
Vitamina A - Retinol;µg/dL | 1 µmol/L = 28.6 µg/dL;20;Deficiência Severa (<10);Deficiência Moderada (10-19.9);Deficiência Leve (20-37.9);Baixo-Normal (38-56.9);ÓTIMO (57-66);Alto-Normal (66.1-85);Elevado/Risco (>85)
```

---

## Clinical Implications by System

### 1. Ocular Health (Night Vision/Eye Function)

| Retinol Level (µg/dL) | Clinical Manifestation |
|----------------------|------------------------|
| <10 | Xerophthalmia, corneal ulceration, Bitot's spots, keratomalacia, irreversible blindness |
| 10-20 | Night blindness (nyctalopia), impaired dark adaptation, dry conjunctiva |
| 20-38 | Subclinical visual dysfunction, delayed dark adaptation |
| 38-57 | Mild reduction in rhodopsin regeneration, marginal visual performance |
| **57-66** | **Optimal rhodopsin synthesis, excellent night vision** |
| 66-85 | Normal vision maintenance |
| >85 | Potential for vitamin A toxicity symptoms (blurred vision, headaches) |

**Key Evidence:**
- Rhodopsin (visual purple) requires retinal (vitamin A aldehyde) for regeneration
- Night blindness is one of earliest signs of deficiency
- Optimal retinol levels support rapid dark adaptation (<10 minutes)

---

### 2. Immune Function

| Retinol Level (µg/dL) | Immune Status |
|----------------------|---------------|
| <10 | Severe immune compromise, increased mortality from infections (measles, diarrhea, respiratory infections) |
| 10-20 | Impaired T-cell function, reduced antibody response, increased infection severity |
| 20-38 | Subclinical immune dysfunction, prolonged recovery from infections |
| 38-57 | Adequate but not optimal immune response |
| **57-66** | **Optimal T-cell differentiation, balanced Th1/Th2 response, robust mucosal immunity** |
| 66-85 | Maintained immune function |
| >85 | Paradoxical immune dysregulation possible with toxicity |

**Mechanisms:**
- Retinoic acid regulates T-cell differentiation (Th1, Th2, Th17, Treg)
- Essential for IgA production in mucosal immunity
- Required for neutrophil and macrophage function
- Maintains epithelial barrier integrity (gut, respiratory, urogenital)

---

### 3. Reproductive Health

#### General Adults

| Retinol Level (µg/dL) | Reproductive Impact |
|----------------------|---------------------|
| <20 | Impaired spermatogenesis (men), menstrual irregularities (women) |
| 20-38 | Suboptimal fertility markers |
| 38-57 | Adequate reproductive function |
| **57-66** | **Optimal fertility, hormone synthesis** |
| 66-85 | Normal reproductive health |
| >85 | Potential endocrine disruption |

#### Pregnancy-Specific Considerations

| Dietary Intake | Serum Level Risk | Teratogenic Risk |
|---------------|------------------|------------------|
| <700 µg/day | Deficiency risk | Fetal growth restriction, immune impairment |
| 700-3,000 µg/day | Safe range | No increased risk |
| **>3,000 µg/day (10,000 IU)** | **Elevated serum risk** | **Craniofacial, cardiac, thymic, CNS malformations** |
| >25,000 IU/day | Toxicity likely | High teratogenic risk (critical period: weeks 3-8) |

**Critical Notes:**
- **EFSA 2024:** Retained UL of 3,000 µg RE/day for pregnant women
- **Teratogenicity is dose and timing-dependent** (first trimester most critical)
- **Beta-carotene (provitamin A) is NOT teratogenic** - safe alternative in pregnancy
- Serum levels >85 µg/dL in pregnancy warrant immediate supplementation review

---

### 4. Liver Health (Hepatotoxicity)

| Intake Duration | Daily Intake | Serum Level | Hepatotoxicity Risk |
|----------------|-------------|-------------|---------------------|
| Acute (days) | <100,000 IU | Variable | Minimal |
| Acute | >100,000 IU | Spike >100 µg/dL | Acute toxicity (rare in adults) |
| Chronic (months-years) | 10,000-25,000 IU | 70-90 µg/dL | Low risk, monitor liver enzymes |
| Chronic | **>25,000 IU** | **>85-100 µg/dL** | **Moderate risk: hepatomegaly, elevated ALT/AST** |
| Chronic (>1 year) | **>40,000 IU** | **>100 µg/dL** | **High risk: fibrosis, portal hypertension, cirrhosis** |

**Pathophysiology:**
- Hepatic stellate cell activation → fibrosis
- Portal hypertension without frank cirrhosis (reversible if caught early)
- Liver stores ~80% of body's vitamin A (as retinyl esters)
- Alcohol consumption potentiates hepatotoxicity

**Monitoring:**
- Serum retinol >85 µg/dL → Check ALT, AST, GGT, bilirubin
- Elevated liver enzymes + high retinol → Discontinue supplements immediately
- Consider liver ultrasound/elastography if chronic elevation

---

### 5. Vitamin D Interaction (Critical for Functional Medicine)

**Antagonistic Relationship:**
- High vitamin A can inhibit vitamin D receptor (VDR) signaling
- High vitamin D can deplete vitamin A stores
- Both vitamins compete for retinoic X receptor (RXR) heterodimerization

**Proposed Optimal Ratios (controversial):**
- **Weston A. Price Foundation:** 5:1 to 10:1 (A:D by weight)
- **Example:** If taking 5,000 IU vitamin D → consider 25,000-50,000 IU vitamin A weekly (controversial and NOT universally accepted)

**Practical Approach:**
- Monitor BOTH serum retinol AND 25(OH)D levels
- Target: Retinol 57-66 µg/dL + 25(OH)D 40-60 ng/mL
- Avoid high-dose single nutrient supplementation
- Use multivitamins with balanced ratios

**Warning Signs of Imbalance:**
- High vitamin A (>85 µg/dL) + Low vitamin D (<30 ng/mL) → Increased fracture risk
- Low vitamin A (<38 µg/dL) + High vitamin D (>80 ng/mL) → Impaired immune function

---

## Longevity & Performance Optimization

### Functional Medicine Targets (OptimalDX)

**Target Range: 57-66 µg/dL (1.99-2.30 µmol/L)**

**Rationale:**
1. **Disease Prevention:** Levels <57 µg/dL associated with:
   - Increased oxidative stress
   - Subclinical inflammation (elevated hs-CRP)
   - Suboptimal cognitive function
   - Reduced exercise recovery

2. **Longevity Markers:** Optimal retinol supports:
   - Telomere maintenance
   - Reduced cellular senescence
   - Enhanced mitochondrial function
   - Balanced mTOR/AMPK signaling

3. **Performance Markers:**
   - Optimal muscle protein synthesis
   - Enhanced post-exercise recovery
   - Improved skin barrier function (anti-aging)
   - Cognitive performance and neuroprotection

**Evidence from Longevity Research:**
- Vitamin A recognized as "longevity vitamin" (Ames triage theory)
- Modest deficiencies accelerate aging processes
- Optimal levels (not excessive) correlate with extended healthspan

---

## Clinical Decision Algorithm

### Step 1: Assess Serum Retinol Level

```
[Serum Retinol Result]
         |
    _____|_____
   |           |
 <38        38-98
   |           |
Deficiency  Within Reference
   |           |
   |       ___|____
   |      |        |
   |    <57     57-66    >66
   |      |        |       |
   |  Suboptimal Optimal High
```

### Step 2: Risk Stratification Actions

**Level 0-1 (Severe Deficiency, <20 µg/dL):**
- **Immediate Action:** High-dose supplementation (25,000-50,000 IU/day for 1-2 weeks, then taper)
- **Workup:** Assess for malabsorption (celiac, IBD, pancreatic insufficiency)
- **Monitor:** Recheck in 4-6 weeks
- **Referral:** Consider ophthalmology if visual symptoms

**Level 2-3 (Mild Deficiency/Low-Normal, 20-56.9 µg/dL):**
- **Supplementation:** 5,000-10,000 IU/day (or 25,000 IU 2-3x/week)
- **Dietary:** Increase liver, egg yolks, dairy, fortified foods
- **Duration:** 8-12 weeks
- **Recheck:** Every 3 months until optimal
- **Consider:** Fat malabsorption workup if persistent

**Level 4 (OPTIMAL, 57-66 µg/dL):**
- **Maintain:** Current intake/supplementation
- **Dietary:** Encourage food sources (liver 1x/week, eggs, dairy, orange/yellow vegetables)
- **Monitor:** Annually or if symptoms develop
- **Avoid:** Excessive supplementation (>10,000 IU/day without indication)

**Level 5-6 (High-Normal, 66.1-85 µg/dL):**
- **Review:** Supplement intake - may need dose reduction
- **Assess:** Dietary sources (excessive liver consumption?)
- **Monitor:** Liver function tests (ALT, AST) if sustained
- **Recheck:** 3-6 months

**Level 6+ (Elevated, >85 µg/dL):**
- **Stop:** All vitamin A supplements immediately
- **Workup:**
  - Comprehensive metabolic panel (liver function)
  - Rule out pregnancy (critical if female of childbearing age)
  - Medication review (isotretinoin, acitretin)
- **Dietary:** Eliminate high vitamin A foods temporarily
- **Monitor:** Recheck monthly until <70 µg/dL
- **Referral:** Hepatology if liver enzymes elevated or symptoms of toxicity

---

## Symptoms by Level

### Deficiency Symptoms (Levels 0-3)

**Early/Mild (20-38 µg/dL):**
- Night blindness, delayed dark adaptation
- Dry skin, follicular hyperkeratosis
- Dry eyes, conjunctival xerosis
- Frequent infections (respiratory, GI)
- Slow wound healing

**Moderate (10-20 µg/dL):**
- Progressive night blindness
- Bitot's spots (conjunctival keratinization)
- Impaired taste and smell
- Anemia (unresponsive to iron)
- Growth retardation (children/adolescents)

**Severe (<10 µg/dL):**
- Xerophthalmia (severe dry eye)
- Corneal ulceration, keratomalacia
- Blindness (irreversible if untreated)
- Severe infections with high mortality
- Stunted growth

### Toxicity Symptoms (Level 6+)

**Acute Toxicity (>200 µg/dL, rare):**
- Nausea, vomiting
- Severe headache, dizziness
- Blurred vision
- Muscle incoordination
- Increased intracranial pressure (pseudotumor cerebri)

**Chronic Toxicity (>85 µg/dL sustained):**
- Dry, pruritic skin
- Desquamation, alopecia
- Cheilitis, glossitis
- Hepatomegaly, liver tenderness
- Bone/joint pain
- Fatigue, irritability
- Hyperlipidemia
- Increased fracture risk (osteoporosis)

---

## Dietary Sources & Supplementation

### Top Food Sources (Preformed Vitamin A - Retinol)

| Food | Serving | Vitamin A (µg RAE) | % RDA (900 µg) |
|------|---------|-------------------|----------------|
| Beef liver (cooked) | 85g (3oz) | 6,582 | 731% |
| Lamb liver (cooked) | 85g | 7,390 | 821% |
| Cod liver oil | 1 tsp (4.5g) | 1,350 | 150% |
| Chicken liver (cooked) | 85g | 3,652 | 406% |
| Egg yolk | 1 large | 80 | 9% |
| Whole milk | 240mL (1 cup) | 112 | 12% |
| Butter | 1 tbsp (14g) | 95 | 11% |
| Cheddar cheese | 28g (1oz) | 75 | 8% |

**Note:** One serving of liver per week can meet entire weekly requirement

### Provitamin A Sources (Beta-Carotene - Non-Toxic)

| Food | Serving | Beta-Carotene (µg RAE) |
|------|---------|----------------------|
| Sweet potato (baked) | 1 medium | 1,403 |
| Carrot (raw) | 1 medium | 509 |
| Spinach (cooked) | 1/2 cup | 573 |
| Kale (cooked) | 1 cup | 885 |
| Cantaloupe | 1/2 medium | 135 |
| Red bell pepper | 1 medium | 152 |

**Beta-Carotene Conversion:**
- 12:1 ratio (12 µg beta-carotene = 1 µg RAE)
- Conversion efficiency varies (genetics, gut health, fat intake)
- Safe even at high intakes (no toxicity, only carotenodermia - harmless orange skin)

### Supplementation Strategies

**For Deficiency (Levels 0-3):**
- **Initial:** 25,000-50,000 IU/day x 1-2 weeks (medical supervision)
- **Maintenance:** 10,000 IU/day x 8-12 weeks
- **Form:** Retinyl palmitate or retinyl acetate (preformed)
- **With food:** Fat-containing meal for absorption

**For Optimization (Level 3-4):**
- **Dose:** 3,000-5,000 IU/day
- **Frequency:** Daily or 10,000 IU 3x/week
- **Form:** Mixed (50% preformed, 50% beta-carotene) for safety
- **Monitoring:** Recheck every 3-6 months

**For Maintenance (Level 4-5):**
- **Food-first approach:** Liver 1x/week + daily eggs/dairy
- **Supplementation:** 2,500-5,000 IU/day (if dietary intake inadequate)
- **Multivitamin:** Most contain 2,500-5,000 IU (often adequate)

**Pregnancy Considerations:**
- **Maximum:** 3,000 µg/day (10,000 IU/day) - do NOT exceed
- **Preferred:** Beta-carotene supplements (safe, non-teratogenic)
- **Prenatal vitamins:** Typically 750-770 µg (safe)

---

## Laboratory Considerations

### Test Methodology
- **Preferred:** Serum retinol via HPLC (high-performance liquid chromatography)
- **Fasting:** Not required, but morning sample preferred
- **Stability:** Protect from light, analyze within 4 hours or freeze

### Limitations of Serum Retinol
- **Acute phase reactant:** Decreases with inflammation/infection (false low)
- **Homeostatic regulation:** Remains stable until liver stores depleted (late marker)
- **Doesn't reflect liver stores:** RBP (retinol-binding protein) tightly regulates release
- **Alternative markers (if available):**
  - Retinol-binding protein (RBP)
  - Retinyl esters (toxicity marker if elevated)
  - Modified relative dose-response (MRDR) test (research)

### When to Test
- **Screening:** Not routine unless high-risk population
- **Indications:**
  - Malabsorption syndromes (IBD, celiac, cystic fibrosis, pancreatitis)
  - Chronic liver disease
  - Night blindness or ocular symptoms
  - Recurrent infections
  - Functional medicine optimization
  - Monitoring supplementation (recheck 3 months after initiation)

---

## Special Populations

### 1. Older Adults (65+ years)
- **Risk:** Both deficiency (malabsorption, poor diet) and toxicity (supplements)
- **Target:** 57-66 µg/dL (may need supplementation)
- **Caution:** Higher fracture risk with excess vitamin A + low vitamin D
- **Recommendation:** 5,000 IU/day max unless deficient

### 2. Vegetarians/Vegans
- **Risk:** Deficiency (no preformed vitamin A in plant foods)
- **Conversion:** Beta-carotene to retinol inefficient (genetics, gut health)
- **Target:** 57-66 µg/dL (often need supplementation)
- **Recommendation:** 3,000-5,000 IU preformed vitamin A daily OR high beta-carotene intake (15,000-25,000 IU equivalent)

### 3. Malabsorption Disorders
- **Conditions:** Celiac disease, Crohn's disease, ulcerative colitis, cystic fibrosis, chronic pancreatitis, post-bariatric surgery
- **Risk:** Severe deficiency despite adequate intake
- **Monitoring:** Test every 6-12 months
- **Supplementation:** Higher doses (10,000-25,000 IU/day), may need IM injections if severe

### 4. Liver Disease
- **Paradox:** Both deficiency (impaired storage/release) and toxicity risk (impaired clearance)
- **Testing:** Essential - serum retinol + RBP
- **Caution:** Avoid high-dose supplementation (cirrhosis patients at risk for toxicity)
- **Recommendation:** Food sources preferred, low-dose supplements (2,500-5,000 IU/day) if deficient

### 5. Alcohol Use Disorder
- **Risk:** Depletion of liver stores + malabsorption
- **Interaction:** Alcohol + high vitamin A = synergistic hepatotoxicity
- **Management:** Correct deficiency but avoid high doses during active drinking
- **Recommendation:** 5,000-10,000 IU/day only after alcohol cessation

---

## Evidence Summary (2023-2026)

### Key Studies & Guidelines

1. **EFSA Scientific Opinion (June 2024)**
   - Retained UL of 3,000 µg RE/day for all adults including pregnancy
   - Teratogenicity confirmed as critical effect
   - Beta-carotene NOT teratogenic or toxic

2. **Vitamin A Toxicity and Hepatic Pathology Review (2025)**
   - Comprehensive analysis of liver damage mechanisms
   - Hepatic stellate cell activation identified as key pathway
   - Reversibility possible if caught early

3. **OptimalDX Functional Reference Ranges (2024)**
   - Optimal range: 57-66 µg/dL (1.99-2.30 µmol/L)
   - Based on functional health outcomes, not disease absence
   - Narrower than standard lab ranges

4. **Longevity Vitamins Review (Ames, ongoing)**
   - Vitamin A classified as longevity vitamin
   - Triage theory: Modest deficiencies accelerate aging
   - Optimal levels support healthspan extension

5. **Vitamin A-D Interaction Research (2024)**
   - Antagonistic effects confirmed at high doses
   - Optimal ratio remains controversial (4:1 to 10:1 A:D)
   - Recommendation: Monitor both, avoid megadoses

### Gaps in Evidence
- Optimal ratio of vitamin A:D for longevity (human RCTs lacking)
- Long-term outcomes of maintaining "optimal" vs "normal" ranges
- Genetic polymorphisms affecting beta-carotene conversion (BCO1 gene)
- Sex differences in vitamin A metabolism and requirements

---

## Clinical Pearls

1. **U-Shaped Curve:** Both deficiency AND excess are harmful - aim for optimal middle range

2. **Liver is Key:** One serving/week can meet needs; excessive liver consumption causes toxicity

3. **Pregnancy Alert:** NEVER exceed 10,000 IU/day (3,000 µg/day) - teratogenic risk

4. **Beta-Carotene is Safe:** No toxicity risk, excellent for pregnancy and high-risk individuals

5. **Inflammation Lowers Levels:** Acute illness/infection temporarily decreases serum retinol (wait 2-4 weeks post-illness to test)

6. **Fat Required:** Vitamin A is fat-soluble - take with meals containing fat for absorption

7. **Vitamin D Balance:** Monitor BOTH vitamins - high A with low D increases fracture risk

8. **Toxicity is Reversible:** Stop supplements, levels normalize in weeks-months (liver damage may take longer)

9. **Functional Medicine Target:** 57-66 µg/dL for optimal health, performance, longevity

10. **Food First:** Whole food sources (liver, eggs, dairy, colorful vegetables) superior to supplements for most people

---

## References

1. National Institutes of Health Office of Dietary Supplements. (2025). Vitamin A and Carotenoids - Health Professional Fact Sheet. Retrieved from https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/

2. National Center for Biotechnology Information. (2025). Vitamin A - StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK482362/

3. National Center for Biotechnology Information. (2025). Vitamin A Toxicity - StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK532916/

4. National Center for Biotechnology Information. (2025). Vitamin A - LiverTox. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK548165/

5. National Center for Biotechnology Information. (2025). Vitamin A toxicity and hepatic pathology: A comprehensive review. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12400428/

6. European Food Safety Authority. (2024). Scientific opinion on the tolerable upper intake level for preformed vitamin A and β-carotene. EFSA Journal. Retrieved from https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2024.8814

7. OptimalDX. (2024). Vitamin Biomarkers: Vitamin A. Retrieved from https://www.optimaldx.com/research-blog/vitamin-biomarkers-vitamin-a

8. Merck Manual Professional Edition. (2024). Vitamin A Deficiency - Nutritional Disorders. Retrieved from https://www.merckmanuals.com/professional/nutritional-disorders/vitamin-deficiency-dependency-and-toxicity/vitamin-a-deficiency

9. National Center for Biotechnology Information. (2018). Prolonging healthy aging: Longevity vitamins and proteins. Retrieved from https://ncbi.nlm.nih.gov/pmc/articles/PMC6205492

10. American Journal of Clinical Nutrition. (2000). Vitamin A in pregnancy: requirements and safety limits. Retrieved from https://ajcn.nutrition.org/article/S0002-9165(23)07164-2/fulltext

11. New England Journal of Medicine. (1995). Teratogenicity of High Vitamin A Intake. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJM199511233332101

12. UNITSLAB.COM. Retinol (Vitamin A1) conversion calculator. Retrieved from https://unitslab.com/node/212

13. The Weston A. Price Foundation. Update on Vitamins A and D. Retrieved from https://www.westonaprice.org/health-topics/abcs-of-nutrition/update-on-vitamins-a-and-d/

14. Institute of Medicine (US) Panel on Micronutrients. (2001). Vitamin A - Dietary Reference Intakes. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK222318/

15. Endocrine Society. (2024). Vitamin D for the Prevention of Disease. Retrieved from https://www.endocrine.org/clinical-practice-guidelines/vitamin-d-for-prevention-of-disease

---

## CSV Output for Database Import

### 7-Level Format (Recommended)
```csv
Nome;Unidade | Conversão;20;Nível 0;Nível 1;Nível 2;Nível 3;Nível 4;Nível 5;Nível 6
Vitamina A (Retinol);µg/dL | 1 µmol/L = 28.6 µg/dL;20;Deficiência Severa (<10);Deficiência Moderada (10-19.9);Deficiência Leve (20-37.9);Baixo-Normal (38-56.9);ÓTIMO (57-66);Alto-Normal (66.1-85);Elevado/Risco (>85)
```

### 9-Level Format (Detailed)
```csv
Nome;Unidade | Conversão;20;Nível 0;Nível 1;Nível 2;Nível 3;Nível 4;Nível 5;Nível 6;Nível 7;Nível 8
Vitamina A (Retinol);µg/dL | 1 µmol/L = 28.6 µg/dL;20;Deficiência Crítica (<10);Deficiência Severa (10-15);Deficiência Moderada (15.1-19.9);Deficiência Leve (20-37.9);Baixo-Normal (38-56.9);ÓTIMO (57-66);Alto-Normal (66.1-75);Normal Superior (75.1-85);Elevado/Toxicidade (>85)
```

---

**Document Version:** 1.0
**Author:** Functional Medicine Risk Stratification System
**Review Date:** January 2026
**Next Update:** January 2027 or when new guidelines published
